Fusion Pharmaceuticals Radiopharmaceuticals Platform 2021

Fusion Pharmaceuticals presents its targeted alpha therapy platform for developing next-generation radiopharmaceuticals focused on precision oncology applications. The company showcases its technology approach to creating innovative cancer therapeutics through advanced radiopharmaceutical development.